4.6 Article

Toll-Like Receptor 4 Polymorphisms (896A/G and 1196C/T) as an Indicator of COVID-19 Severity in a Convenience Sample of Egyptian Patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?

Simone Cristina Soares Brandao et al.

Summary: The severe form of COVID-19 is characterized by an abnormal and exacerbated immune response, especially in patients with obesity, diabetes, hypertension, and atherosclerosis. The virus spike protein interacts strongly with TLR4, leading to a cytokine storm and multiple organ failure in some cases.

CYTOKINE & GROWTH FACTOR REVIEWS (2021)

Review Cell Biology

COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation

Mohamed M. Aboudounya et al.

Summary: Mortality in COVID-19 is caused by respiratory failure, heart failure, and sepsis/multiorgan failure. TLR4, an innate immune receptor, recognizes viral proteins and triggers immune responses. SARS-CoV-2 binds to TLR4, potentially leading to inflammation and multi-organ injury.

MEDIATORS OF INFLAMMATION (2021)

Review Biochemistry & Molecular Biology

Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4

Carmela Conte

Summary: Parkinson's disease is a common neurodegenerative motor disorder characterized by selective degeneration of dopaminergic neurons. The activation of toll-like receptors and neuroinflammatory immune response may play a significant role in the pathogenesis of PD. COVID-19 patients exhibit various neurological symptoms, potentially linked to the involvement of SARS-CoV-2 in neuronal death through TLR4 signaling pathway and interaction with alpha-SYN.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Editorial Material Biochemistry & Molecular Biology

Calming the cytokine storm in COVID-19

Randy Q. Cron et al.

Summary: Cytokine blockade can improve the survival rate of COVID-19 patients at risk of respiratory failure, with timing and patient selection being crucial factors.

NATURE MEDICINE (2021)

Article Anesthesiology

ICU admission of COVID-19 patients: Identification of risk factors

Shaimaa H. Fouad et al.

Summary: The study found that elderly, smokers, diabetic, and hypertensive patients with COVID-19 are more likely to require ICU admission. These risk factors need to be given more attention during the course of the disease.

EGYPTIAN JOURNAL OF ANAESTHESIA (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Time Course of Lung Changes a Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19 )

Feng Pan et al.

RADIOLOGY (2020)

Letter Hematology

Signals of Th2 immune response from COVID-19 patients requiring intensive care

Luca Roncati et al.

ANNALS OF HEMATOLOGY (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19 Definition and Evaluation

Mathias Prokop et al.

RADIOLOGY (2020)

Article Endocrinology & Metabolism

TLR4 Polymorphisms (896A>G and 1196C>T) Affect the Predisposition to Diabetic Nephropathy in Type 2 Diabetes Mellitus

Narges Khaghanzadeh et al.

DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2020)

Article Biochemical Research Methods

Expansion of Single Cell Transcriptomics Data of SARS-CoV Infection in Human Bronchial Epithelial Cells to COVID-19

Reza Zolfaghari Emameh et al.

BIOLOGICAL PROCEDURES ONLINE (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis

Marco Francone et al.

EUROPEAN RADIOLOGY (2020)

Review Immunology

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies

Yujun Tang et al.

FRONTIERS IN IMMUNOLOGY (2020)

Letter Biochemistry & Molecular Biology

Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study

Li Tan et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Genetics & Heredity

The role of Toll-like receptor 4 polymorphisms in vaccine immune response

P. Pellegrino et al.

PHARMACOGENOMICS JOURNAL (2016)

Article Microbiology

Toll-Like Receptor Signaling and Its Inducible Proteins

Takashi Satoh et al.

MICROBIOLOGY SPECTRUM (2016)

Article Gastroenterology & Hepatology

Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms: New data and a meta-analysis

Nezha Senhaji et al.

BMC GASTROENTEROLOGY (2014)

Article Immunology

Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis

S Pabst et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)

Article Immunology

Toll-like receptor (TLR) 2 and 4 mutations in periodontal disease

M Folwaczny et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)

Article Medicine, General & Internal

Toll-like receptor 4 polymorphisms and atherogenesis

S Kiechl et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Article Genetics & Heredity

TLR4 mutations are associated with endotoxin hyporesponsiveness in humans

NC Arbour et al.

NATURE GENETICS (2000)